These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29522126)

  • 1. Retinal Deposits in a Young Woman.
    Oliver R; Sallam AB; Uwaydat SH
    JAMA Ophthalmol; 2018 Jun; 136(6):708-709. PubMed ID: 29522126
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of velaglucerase alfa enzyme replacement therapy on red blood cell properties in Gaucher disease.
    Franco M; Reihani N; Marin M; De Person M; Billette de Villemeur T; Rose C; Colin Y; Moussa F; Belmatoug N; Le Van Kim C
    Am J Hematol; 2017 Sep; 92(9):E561-E563. PubMed ID: 28621801
    [No Abstract]   [Full Text] [Related]  

  • 3. The appearance of newly identified intraocular lesions in Gaucher disease type 3 despite long-term glucocerebrosidase replacement therapy.
    Sawicka-Gutaj N; Machaczka M; Kulińska-Niedziela I; Bernardczyk-Meller J; Gutaj P; Sowiński J; Ruchała M
    Ups J Med Sci; 2016 Aug; 121(3):192-5. PubMed ID: 27064303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fundus abnormalities in a patient with type I Gaucher's disease with 12-year follow-up.
    Wang TJ; Chen MS; Shih YF; Hwu WL; Lai MY
    Am J Ophthalmol; 2005 Feb; 139(2):359-62. PubMed ID: 15734007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: a case report.
    Martinez-Redondo C; Ortuño FJ; Lozano ML; Jerez A; del Mar Osma M; Giraldo P; Vicente V
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S265-7. PubMed ID: 19562501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional retinal changes in Gaucher disease.
    Seidova SF; Kotliar K; Foerger F; Klopfer M; Lanzl I
    Doc Ophthalmol; 2009 Apr; 118(2):151-4. PubMed ID: 18777184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocerebrosidase level in the cerebrospinal fluid during enzyme replacement therapy--unsuccessful treatment of the neurological abnormality in type 2 Gaucher disease.
    Migita M; Hamada H; Fujimura J; Watanabe A; Shimada T; Fukunaga Y
    Eur J Pediatr; 2003 Jul; 162(7-8):524-525. PubMed ID: 12845529
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of the pre-retinal opacities in Gaucher Disease using spectral domain optical coherent tomography.
    Sheck LH; Wilson CJ; Vincent AL
    Ophthalmic Genet; 2012 Dec; 33(4):253-6. PubMed ID: 22950450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme replacement therapy in a child with Gaucher disease.
    Masood Y; Ali AS
    J Coll Physicians Surg Pak; 2006 Dec; 16(12):786-8. PubMed ID: 17125641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.
    Charrow J; Andersson HC; Kaplan P; Kolodny EH; Mistry P; Pastores G; Prakash-Cheng A; Rosenbloom BE; Scott CR; Wappner RS; Weinreb NJ
    J Pediatr; 2004 Jan; 144(1):112-20. PubMed ID: 14722528
    [No Abstract]   [Full Text] [Related]  

  • 11. Patients with Gaucher type 1: Switching from imiglucerase to miglustat therapy.
    Canda E; Kose M; Kagnici M; Ucar SK; Sozmen EY; Coker M
    Blood Cells Mol Dis; 2018 Feb; 68():180-184. PubMed ID: 28111116
    [No Abstract]   [Full Text] [Related]  

  • 12. Alglucerase (Ceredase).
    Wiltink EH; Hollak CE
    Pharm World Sci; 1996 Jan; 18(1):16-9. PubMed ID: 8861826
    [No Abstract]   [Full Text] [Related]  

  • 13. Early access experience with VPRIV(®): recommendations for 'core data' collection.
    Hughes DA; Al-Sayed M; Belmatoug N; Bodamer O; Böttcher T; Cappellini M; Cohen IJ; Eagleton T; Elstein D; Giraldo P; Jones S; Kaplinsky C; Lund A; Machaczka M; Mengel E; Pastores GM; Rosenbaum H; Sjo M; Tiling N; Tsaftaridis P; Zimran A; Weinreb N
    Blood Cells Mol Dis; 2011 Aug; 47(2):140-2. PubMed ID: 21146428
    [No Abstract]   [Full Text] [Related]  

  • 14. Markers of coagulation activation and enhanced fibrinolysis in Gaucher type 1 patient: Effects of enzyme replacement therapy.
    Mitrovic M; Sumarac Z; Antic D; Bogdanovic A; Elezovic I; Vukosavljevic D; Ignjatovic S; Majkic-Singh N; Suvajdzic N
    Blood Cells Mol Dis; 2012 Jun; 49(1):58-9. PubMed ID: 22459893
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholangiocarcinoma occurring in a patient with type 1 Gaucher disease treated with velaglucerase alfa enzyme replacement therapy: First case report.
    Holubar J; Bres V; Costes-Martineau V; Pers YM
    Blood Cells Mol Dis; 2018 Feb; 68():112-114. PubMed ID: 28559130
    [No Abstract]   [Full Text] [Related]  

  • 16. Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014.
    Barranger JA; Brady RO; Grabowski GA; Mankin H; Mistry PK; Weinreb NJ
    Am J Hematol; 2014 May; 89(5):457-8. PubMed ID: 24488939
    [No Abstract]   [Full Text] [Related]  

  • 17. Gaucher disease.
    Mignot C; Gelot A; De Villemeur TB
    Handb Clin Neurol; 2013; 113():1709-15. PubMed ID: 23622393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multifocal electroretinography in ophtalmological symptoms in patients with antiphospholipid syndrome].
    Avetisov SE; Smirnova TV; Kozlovskaia NL; Kazarian EE; Budzinskaia MV
    Vestn Oftalmol; 2009; 125(1):46-9. PubMed ID: 19284102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
    Laudemann K; Moos L; Mengel E; Lollert A; Hoffmann C; Brixius-Huth M; Wagner D; Düber C; Staatz G
    Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home treatment with enzyme replacement therapy in a 5-year-old girl with type 2 Gaucher disease.
    Migita M; Shimada T; Hayakawa J; Zhi CL; Morita T; Ohshiro K; Fukunaga Y
    Pediatr Int; 2003 Jun; 45(3):363-5. PubMed ID: 12828600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.